Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2
Kristina Lorenz1, Martin J Lohse, Ursula Quitterer
1Institut für Pharmakologie und Toxikologie, Versbacher Strasse 9, D-97078 Würzburg, Germany.
Abstract:
Feedback inhibition is a fundamental principle in signal transduction allowing rapid adaptation to different stimuli. In mammalian cells, the major feedback inhibitor for G-protein-coupled receptors (GPCR) is G-protein-coupled receptor kinase 2 (GRK-2), which phosphorylates activated receptors, uncouples them from G proteins and initiates their internalization. The functions of GRK-2 are indispensable and need to be tightly controlled. Dysregulation promotes disorders such as hypertension or heart failure. In our search for a control mechanism for this vital kinase, here we show that the Raf kinase inhibitor protein (RKIP) is a physiological inhibitor of GRK-2. After stimulation of GPCR, RKIP dissociates from its known target, Raf-1 (refs 6-8), to associate with GRK-2 and block its activity. This switch is triggered by protein kinase C (PKC)-dependent phosphorylation of the RKIP on serine 153. The data delineate a new principle in signal transduction: by activating PKC, the incoming receptor signal is enhanced both by removing an inhibitor from Raf-1 and by blocking receptor internalization. A physiological role for this mechanism is shown in cardiomyocytes in which the downregulation of RKIP restrains beta-adrenergic signalling and contractile activity.
Insights
Raf kinase inhibitor protein (RKIP) inhibits G-protein-coupled receptor kinase 2 (GRK-2). Upon G-protein-coupled receptor stimulation, RKIP switches targets to block GRK-2, enhancing cellular signaling and adaptation.
Area of Science:
- Cellular signaling
- Signal transduction pathways
- Molecular biology
Background:
- Feedback inhibition is crucial for signal transduction and cellular adaptation.
- G-protein-coupled receptor kinase 2 (GRK-2) is a key regulator of G-protein-coupled receptors (GPCRs), controlling their activity and internalization.
- Dysregulation of GRK-2 is implicated in cardiovascular disorders like hypertension and heart failure.
Purpose of the Study:
- To identify physiological mechanisms controlling G-protein-coupled receptor kinase 2 (GRK-2) activity.
- To investigate the role of Raf kinase inhibitor protein (RKIP) as a regulator of GRK-2.
- To elucidate a novel feedback inhibition mechanism in G-protein-coupled receptor signaling.
Main Methods:
- Investigated the interaction between RKIP and GRK-2 following GPCR stimulation.
- Utilized protein kinase C (PKC) phosphorylation assays to determine the trigger for RKIP target switching.
- Examined the functional consequences of RKIP-GRK-2 interaction in cardiomyocytes.
Main Results:
- Raf kinase inhibitor protein (RKIP) was identified as a physiological inhibitor of GRK-2.
- Upon GPCR stimulation, RKIP dissociates from Raf-1 to bind and inhibit GRK-2.
- PKC-dependent phosphorylation of RKIP at serine 153 mediates this target switch.
- This mechanism enhances GPCR signaling by simultaneously inhibiting GRK-2 and relieving inhibition of Raf-1.
- Downregulation of RKIP in cardiomyocytes impairs beta-adrenergic signaling and contractile function.
Conclusions:
- RKIP acts as a critical feedback inhibitor of GRK-2, revealing a new regulatory principle in signal transduction.
- The RKIP-GRK-2 axis provides a mechanism to fine-tune GPCR signaling responses.
- This pathway has significant implications for understanding and potentially treating cardiovascular diseases associated with GRK-2 dysregulation.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
Related Concept Videos
The Ras Gene
Ras is a...
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
